NCT06713343

Brief Summary

When the instruction guidelines of classical laryngeal mask airways (cLMAs) were examined, it was seen that they should be stored between 10 °C and 25 °C. The purpose of this study is to test the effect on postoperative sore throat of LMA stored at different temperatures. The patients to be admitted for elective surgery will be divided into two groups. Patients in Group L will be ventilated with a classical laryngeal mask airways (cLMA) stored at 10 °C to 12 °C (low temperatures), while patients in Group R will be ventilated with a classical laryngeal mask airways (cLMA) stored at 22 °C to 25 °C (room temperatures). Postoperative complaints of sore throat, dysphagia, dysphonia and cough at 0, 1, 6, 12 and 24 hours will be questioned and noted.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
172

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Nov 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 7, 2024

Completed
4 days until next milestone

Study Start

First participant enrolled

November 11, 2024

Completed
22 days until next milestone

First Posted

Study publicly available on registry

December 3, 2024

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 30, 2025

Completed
4 days until next milestone

Study Completion

Last participant's last visit for all outcomes

February 3, 2025

Completed
Last Updated

September 24, 2025

Status Verified

February 1, 2025

Enrollment Period

3 months

First QC Date

November 7, 2024

Last Update Submit

September 23, 2025

Conditions

Keywords

laryngeal mask airwaypostoperative sore throatLMA

Outcome Measures

Primary Outcomes (1)

  • Postoperative Sore Throat

    Postoperative sore throat will be evaluated according to the Numeric Rating Scale (NRS) pain score. The Numeric Rating Scale (NRS) is the simplest and most commonly used numeric scale in which the patient rates the pain from 0 (no pain) to 10 (worst pain imaginable).

    Sore throat at postoperatively 0, 1, 6, 12 and 24 hours will be questioned and noted.

Secondary Outcomes (2)

  • Postoperative Dysphagia, Cough and Dysphonia

    Dysphagia, cough and dysphonia at postoperatively 0, 1, 6, 12 and 24 hours will be questioned and noted.

  • Ease of application of laryngeal mask airways

    The duration from opening of mouth for placement until confirmation of laryngeal mask airways placement by capnograph will be measured, within 5 minutes.

Study Arms (2)

Group L

ACTIVE COMPARATOR

Patients in Group L will be ventilated with a classical laryngeal mask (cLMA) stored at 10 °C to 12 °C (low temperatures)

Device: Laryngeal Mask Airways

Group R

ACTIVE COMPARATOR

Patients in Group R will be ventilated with a classical laryngeal mask (cLMA) stored at 22 °C to 25 °C (room temperatures)

Device: Laryngeal Mask Airways

Interventions

The 172 patients who will be admitted for elective surgery will be divided into two groups as Group L and Group R by computer-assisted randomization method. Patients in Group L will be ventilated with a classical laryngeal mask airways (cLMA) stored at 10 °C to 12 °C (low temperatures), while patients in Group R will be ventilated with a classical laryngeal mask airways (cLMA) stored at 22 °C to 25 °C (room temperatures).

Group LGroup R

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Under elective conditions, between 18-65 years of age, those who will receive general anesthesia and ventilation will be provided with a laryngeal mask airways
  • ASA I-III risk group
  • Patients who agreed to be included in the study
  • Estimated duration of anesthesia lasting between 1 hour and 2 hours

You may not qualify if:

  • Patients younger than 18 and older than 65 years old
  • Patients who are incapable of reading, understanding and signing the consent form
  • Hemodynamically unstable patients
  • Patients with orofacial clefts or abnormalities of the oral cavity or pharynx, patients who have undergone oral or laryngeal surgery
  • Patients at high risk of aspiration of gastric contents (pregnant women, those with gastro-esophageal reflux, those with hiatal hernia)
  • Patients do not want to participate in the study
  • Patients with sore throat in the last 30 days before surgeryPatients
  • Patients with advanced dementia
  • Patients with ASA score above III
  • Patients with a Mallampati score of 4
  • Emergency surgical procedures

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ankara Bilkent City Hospital

Ankara, Çankaya, 06800, Turkey (Türkiye)

Location

MeSH Terms

Interventions

Laryngeal Masks

Intervention Hierarchy (Ancestors)

Intubation, IntratrachealAirway ManagementTherapeuticsIntubationInvestigative TechniquesMasksProtective DevicesEquipment and SuppliesPersonal Protective EquipmentManufactured MaterialsTechnology, Industry, and Agriculture

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SCREENING
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prof. MD

Study Record Dates

First Submitted

November 7, 2024

First Posted

December 3, 2024

Study Start

November 11, 2024

Primary Completion

January 30, 2025

Study Completion

February 3, 2025

Last Updated

September 24, 2025

Record last verified: 2025-02

Data Sharing

IPD Sharing
Will not share

Locations